SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-23-005953
Filing Date
2023-07-18
Accepted
2023-07-18 16:30:54
Documents
2
Period of Report
2023-07-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1717
2 POA SIGNED 7/17/2023 poa_esnow72023.txt EX-24 3426
  Complete submission text file 0001562180-23-005953.txt   6495
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O PEAR THERAPEUTICS, INC. 200 STATE STREET, 13TH FLOOR BOSTON MA 02109
Business Address
Snow Ellen (Reporting) CIK: 0001786643 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 231094624